0001209191-16-129450.txt : 20160624 0001209191-16-129450.hdr.sgml : 20160624 20160624082140 ACCESSION NUMBER: 0001209191-16-129450 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160615 FILED AS OF DATE: 20160624 DATE AS OF CHANGE: 20160624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VESSEY RUPERT CENTRAL INDEX KEY: 0001677618 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 161729932 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-06-15 0 0000816284 CELGENE CORP /DE/ CELG 0001677618 VESSEY RUPERT C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 See remarks Common Stock 3650 D Common Stock 135 I 401(k) Plan Stock Option (right to buy) 118.57 2025-02-02 Common Stock 19142 D Stock Option (right to buy) 109.90 2025-05-04 Common Stock 3125 D Stock Option (right to buy) 132.56 2025-07-27 Common Stock 3125 D Stock Option (right to buy) 114.08 2025-11-09 Common Stock 3125 D Stock Option (right to buy) 100.80 2026-02-01 Common Stock 3125 D Stock Option (right to buy) 104.97 2026-05-02 Common Stock 12906 D Restricted Stock Unit Common Stock 11246 D Restricted Stock Unit Common Stock 781 D Restricted Stock Unit Common Stock 5350 D Restricted Stock Unit Common Stock 6731 D The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). The option is immediately exercisable and will vest in four equal annual installments commencing on February 2, 2016. The option is immediately exercisable and will vest in four equal annual installments commencing on May 4, 2016. The option is immediately exercisable and will vest in four equal annual installments commencing on July 27, 2016. The option is immediately exercisable and will vest in four equal annual installments commencing on November 9, 2016. The option is immediately exercisable and will vest in four equal annual installments commencing on February 1, 2017. The option is immediately exercisable and will vest in four equal annual installments commencing on May 2, 2017. The restricted stock units will vest in two annual installments as follows: 5,622 shares on February 2, 2017; 5,623 shares on February 2, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date. The restricted stock unit was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest on May 4, 2018. Vested shares will be delivered to the reporting person on the vesting date. The restricted stock units vest on December 16, 2018. Vested shares will be delivered to the reporting person on the vesting date. The restricted stock units vest on May 2, 2019. Vested shares will be delivered to the reporting person on the vesting date. President, Research and Early Development /s/ Rupert Vessey _________________________________________ Rupert Vessey 2016-06-23 EX-24.3_663604 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Robert J. Hugin, Mark J. Alles and Peter N. Kellogg the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Celgene Corporation (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below. /s/ Rupert Vessey June 20, 2016 Rupert Vessey